Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma Webinar – November 15, 2022

Webinars

LRF’s free webinars are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials, and promising innovative research. Webinars can be listened to live on the telephone or via web streaming. Podcasts of the programs can also be accessed following the live program. Please continue to check this page for updates.

Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Webinar

DATE: Tuesday, November 15, 2022
TIME: 2:00 PM – 3:00 PM EST (11:00 AM PST)

VIRTUAL PROGRAM – This is a virtual event, accessible online and over the phone. Access instructions will be provided after registration. Note: Look for Beacon360 as sender of confirmation and reminder emails.

Featuring

Jennifer Amengual, MD
Hematologist/Oncologist
Assistant Professor of Medicine
Division of Hematology and Oncology
Columbia University Herbert Irving Comprehensive Cancer Center

Program Overview

  • Overview of Relapsed/Refractory DLBCL
  • Considering Second- and Third-Line Treatment Options
  • Update on Clinical Trials
  • Question and Answer Session

Ways to Register

VIRTUAL PROGRAM – This is a virtual event, accessible online and over the phone. Access instructions will be emailed after registration. Note: Beacon360 will email confirmation and reminders.

Call: 800-500-9976
Email: mspellman@lymphoma.org

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, LRF recommends the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from: